The role of nitric oxide in the regulation of glomerular haemodynamics in humans
Open Access
- 5 March 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (6), 1392-1397
- https://doi.org/10.1093/ndt/gfh187
Abstract
Background. According to experimental data, the afferent glomerular arteriole is particularly under control of nitric oxide (NO). By use of pharmacological manoeuvres, we examined whether this finding holds true in the human renal circulation in vivo. Methods. Seventy-seven volunteers (aged 50±9 years) with mild to moderate essential hypertension (n = 57) or arterial normotension (n = 20) were examined. Basal NO activity in the renal circulation was assessed by the change of renal plasma flow (RPF) through systemic infusion of the NO synthase inhibitor, NG-monomethyl-l-arginine (l-NMMA; 4.25 mg/kg). Hypertensive patients were treated over 8 weeks with either the calcium-channel blocker amlodipine or the AT1-receptor blocker valsartan, primarily dilating the afferent and efferent arteriole, respectively. Subsequently, renal haemodynamics and NO activity in the renal circulation were determined again. Results.l-NMMA reduced RPF in normotensive (by 57±70 ml/min/1.73 m2; P2; Pr = 0.39, P2; (P2; (PConclusions. NO plays an important role in the regulation of human glomerular haemodynamics, probably with a greater contribution to afferent than to efferent arteriolar tone in man.Keywords
This publication has 13 references indexed in Scilit:
- Direct comparison of the effects of valsartan and amlodipine on renal hemodynamics in human essential hypertension.American Journal of Hypertension, 2003
- Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly SubjectsCirculation, 2003
- Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension11See Editorial by Noris and Remuzzi, p. 1545.Kidney International, 2002
- Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjectsJournal Of Hypertension, 2002
- Assessment of endothelial function of the renal vasculature in human subjects.American Journal of Hypertension, 2002
- The systemic and renal response to NO inhibition is not modified by angiotensin-II-receptor blockade in healthy humans.Nephrology Dialysis Transplantation, 1999
- Angiotensin II Blockade Does Not Prevent Renal Effects of L-NAME in Sodium-Repleted HumansHypertension, 1997
- Disparate Effects of Calcium Antagonists on Renal Microcirculation.Hypertension Research, 1996
- Glomerular actions of nitric oxideKidney International, 1995
- Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole.JCI Insight, 1993